Profound Medical (PROF) Cash & Equivalents (2023 - 2025)
Historic Cash & Equivalents for Profound Medical (PROF) over the last 3 years, with Q3 2025 value amounting to $24.8 million.
- Profound Medical's Cash & Equivalents fell 846.88% to $24.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.8 million, marking a year-over-year decrease of 846.88%. This contributed to the annual value of $54.9 million for FY2024, which is 10948.38% up from last year.
- Per Profound Medical's latest filing, its Cash & Equivalents stood at $24.8 million for Q3 2025, which was down 846.88% from $35.2 million recorded in Q2 2025.
- In the past 5 years, Profound Medical's Cash & Equivalents ranged from a high of $54.9 million in Q4 2024 and a low of $24.8 million during Q3 2025
- In the last 3 years, Profound Medical's Cash & Equivalents had a median value of $35.2 million in 2025 and averaged $37.4 million.
- The largest annual percentage gain for Profound Medical's Cash & Equivalents in the last 5 years was 10948.38% (2024), contrasted with its biggest fall of 1933.68% (2024).
- Over the past 3 years, Profound Medical's Cash & Equivalents (Quarter) stood at $26.2 million in 2023, then soared by 109.48% to $54.9 million in 2024, then crashed by 54.79% to $24.8 million in 2025.
- Its Cash & Equivalents was $24.8 million in Q3 2025, compared to $35.2 million in Q2 2025 and $46.4 million in Q1 2025.